Iovance Biotherapeutics
IOVA
#5204
Rank
C$1.59 B
Marketcap
$4.86
Share price
4.46%
Change (1 day)
-69.15%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2024 (TTM): -C$0.55 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are C$0.16 Billion. , an increase over its 2023 earnings that were of -C$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.55 Billion-14.17%
2023 -C$0.64 Billion15.46%
2022 -C$0.56 Billion16.39%
2021 -C$0.48 Billion30.83%
2020 -C$0.37 Billion26.62%
2019 -C$0.29 Billion61.29%
2018 -C$0.18 Billion38.09%
2017 -C$0.13 Billion73.16%
2016 -C$74.32 Million92.7%
2015 -C$38.57 Million131.17%
2014 -C$16.69 Million-51.71%
2013 -C$34.55 Million6291.81%
2012 -C$0.55 Million
2008 -C$0.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$48.88 M-108.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$3 Million-99.45% Bahamas